{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:46:29Z","timestamp":1782866789314,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11641-z","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:50:13Z","timestamp":1782863413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of novel perillyl and myrtenyl nucleobase conjugates as dual anti-Alzheimer and antimicrobial agents"],"prefix":"10.1007","author":[{"given":"Saida","family":"Lachhab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soukaina","family":"Elmoussaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Rafya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Az-Eddine","family":"EL Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel R.","family":"Ramalhosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabete P.","family":"Carreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatiha","family":"Benkhalti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh S.","family":"Sanghvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha Ait","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan B.","family":"Lazrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"11641_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.14283\/jpad.2021.15","volume":"8","author":"XX Zhang","year":"2021","unstructured":"Zhang XX, Tian Y, Wang ZT et al (2021) The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention. J Prev Alzheimers Dis 8:313\u2013321. https:\/\/doi.org\/10.14283\/jpad.2021.15","journal-title":"J Prev Alzheimers Dis"},{"key":"11641_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s11064-015-1780-1","volume":"41","author":"M Pandareesh","year":"2016","unstructured":"Pandareesh M, Anand T, Khanum F (2016) Cognition enhancing and neuromodulatory propensity of Bacopa monniera extract against scopolamine induced cognitive impairments in rat hippocampus. Neurochem Res 41:985\u2013999. https:\/\/doi.org\/10.1007\/s11064-015-1780-1","journal-title":"Neurochem Res"},{"key":"11641_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"A Alzheimer","year":"1995","unstructured":"Alzheimer A, Stelzmann RA, Schnitzlein HN et al (1995) An english translation of Alzheimer\u2019s 1907 paper, \u00dcber eine eigenartige Erkankung der Hirnrinde. Clin Anat 8:429\u2013431","journal-title":"Clin Anat"},{"key":"11641_CR4","doi-asserted-by":"publisher","first-page":"107152","DOI":"10.1016\/j.bioorg.2024.107152","volume":"144","author":"C Pathak","year":"2024","unstructured":"Pathak C, Kabra UD (2024) A comprehensive review of multi-target directed ligands in the treatment of Alzheimer\u2019s disease. Bioorg Chem 144:107152. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107152","journal-title":"Bioorg Chem"},{"key":"11641_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05903-y","author":"D Pisa","year":"2017","unstructured":"Pisa D, Alonso R, Fern\u00e1ndez-Fern\u00e1ndez AM et al (2017) Polymicrobial infections in brain tissue from Alzheimer\u2019s disease patients. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-05903-y","journal-title":"Sci Rep"},{"key":"11641_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/path.2449","author":"MA Wozniak","year":"2009","unstructured":"Wozniak MA, Itzhaki RF, Shipley SJ et al (2009) Herpes simplex virus type 1 DNA is located within Alzheimer\u2019s disease amyloid plaques. J Pathol. https:\/\/doi.org\/10.1002\/path.2449","journal-title":"J Pathol"},{"key":"11641_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20133","author":"RF Itzhaki","year":"2006","unstructured":"Itzhaki RF, Wozniak MA, Appelt DM et al (2006) Reactivation of HSV\u20101 in the brain of patients with familial Alzheimer\u2019s disease. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.20133","journal-title":"J Med Virol"},{"key":"11641_CR8","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2008-13403","author":"BJ Balin","year":"2008","unstructured":"Balin BJ, G\u00e9rard HC, Arking EJ et al (2008) Chlamydophila Pneumoniae and the etiology of late-onset Alzheimer\u2019s disease. J Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-2008-13403","journal-title":"J Alzheimers Dis"},{"key":"11641_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2006.00154.x","author":"R Alonso","year":"2006","unstructured":"Alonso R, Pisa D, Fern\u00e1ndez-Fern\u00e1ndez AM et al (2006) Chlamydophila (Chlamydia) pneumoniae in the Alzheimer\u2019s brain. FEMS Immunol Med Microbiol. https:\/\/doi.org\/10.1111\/j.1574-695X.2006.00154.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"11641_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.15599","author":"D Pisa","year":"2015","unstructured":"Pisa D, Alonso R, Carrasco L (2015) Fungal infection in brains of patients with Alzheimer\u2019s disease. Eur J Neurosci. https:\/\/doi.org\/10.1111\/ejn.15599","journal-title":"Eur J Neurosci"},{"key":"11641_CR11","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.3390\/ijms21144920","volume":"21","author":"UH Iqbal","year":"2020","unstructured":"Iqbal UH, Zeng E, Pasinetti GM (2020) The use of antimicrobial and antiviral drugs in Alzheimer\u2019s disease. Int J Mol Sci 21:4341","journal-title":"Int J Mol Sci"},{"key":"11641_CR12","doi-asserted-by":"publisher","first-page":"1467333","DOI":"10.3389\/fnins.2024.1467333","volume":"18","author":"JH Min","year":"2024","unstructured":"Min JH, Sarlus H, Harris RA (2024) MAD\u2014microbial (origin of) Alzheimer\u2019s disease hypothesis: from infection and the antimicrobial response to disruption of key copper-based systems. Front Neurosci 18:1467333. https:\/\/doi.org\/10.3389\/fnins.2024.1467333","journal-title":"Front Neurosci"},{"key":"11641_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1039\/D4MD00630E","volume":"16","author":"A Sharma","year":"2025","unstructured":"Sharma A, Rudrawar S, Bharate SB et al (2025) Recent advancements in the therapeutic approaches for Alzheimer\u2019s disease treatment: current and future perspective. RSC Med Chem 16:652\u2013693. https:\/\/doi.org\/10.1039\/D4MD00630E","journal-title":"RSC Med Chem"},{"key":"11641_CR14","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.3390\/app14093898","volume":"14","author":"E Lima","year":"2024","unstructured":"Lima E, Medeiros J (2024) Terpenes as potential anti-Alzheimer\u2019s disease agents. Appl Sci 14:3898. https:\/\/doi.org\/10.3390\/app14093898","journal-title":"Appl Sci"},{"key":"11641_CR15","doi-asserted-by":"publisher","first-page":"155826","DOI":"10.1016\/j.phymed.2024.155826","volume":"132","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wang G, Li Z et al (2024) Molecular pharmacology and therapeutic advances of monoterpene perillyl alcohol. Phytomedicine 132:155826. https:\/\/doi.org\/10.1016\/j.phymed.2024.155826","journal-title":"Phytomedicine"},{"key":"11641_CR16","doi-asserted-by":"publisher","first-page":"177558","DOI":"10.1016\/j.ejphar.2025.177558","volume":"996","author":"D Chauhan","year":"2025","unstructured":"Chauhan D, Bagri K, Deshmukh R (2025) Neuroprotective effect of perillyl alcohol in sporadic Alzheimer\u2019s disease in rats. Eur J Pharmacol 996:177558. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177558","journal-title":"Eur J Pharmacol"},{"key":"11641_CR17","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1021\/jm500870u","volume":"57","author":"NS Nandurkar","year":"2014","unstructured":"Nandurkar NS, Zhang J, Ye Q et al (2014) The identification of perillyl alcohol glycosides with improved antiproliferative activity. J Med Chem 57:7478\u20137484. https:\/\/doi.org\/10.1021\/jm500870u","journal-title":"J Med Chem"},{"key":"11641_CR18","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.3390\/molecules19056671","volume":"19","author":"Z Hui","year":"2014","unstructured":"Hui Z, Zhang M, Cong L et al (2014) Synthesis and antiproliferative effects of amino-modified perillyl alcohol derivatives. Molecules 19:6671\u20136682. https:\/\/doi.org\/10.3390\/molecules19056671","journal-title":"Molecules"},{"key":"11641_CR19","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.3390\/life13102086","volume":"13","author":"S Dragomanova","year":"2023","unstructured":"Dragomanova S, Andonova V, Volcho K et al (2023) Therapeutic potential of myrtenal and its derivatives\u2014a review. Life 13:2086. https:\/\/doi.org\/10.3390\/life13102086","journal-title":"Life"},{"key":"11641_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/antibiotics12050818","volume":"12","author":"NS Li-Zhulanov","year":"2023","unstructured":"Li-Zhulanov NS, Zaikova NP, Sari S et al (2023) Rational design of new monoterpene-containing azoles and their antifungal activity. Antibiotics 12:818. https:\/\/doi.org\/10.3390\/antibiotics12050818","journal-title":"Antibiotics"},{"key":"11641_CR21","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.6023\/cjoc201801043","volume":"38","author":"G Lin","year":"2018","unstructured":"Lin G, Chen Z, Duan W et al (2018) Synthesis and biological activity of novel myrtenal-derived 2-acyl-1,2,4-triazole-3-thione compounds. Chin J Org Chem 38:2085","journal-title":"Chin J Org Chem"},{"key":"11641_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1365-2133.1964.tb15484.x","volume":"76","author":"DI McCallum","year":"1964","unstructured":"McCallum DI, Johnston ENM, Raju BH (1964) 5-Iodo-2\u2032-deoxyuridine in the treatment of herpes zoster. Br J Dermatol 76:459\u2013462. https:\/\/doi.org\/10.1111\/j.1365-2133.1964.tb15484.x","journal-title":"Br J Dermatol"},{"key":"11641_CR23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3762\/bjoc.7.80","volume":"7","author":"L Brulikova","year":"2011","unstructured":"Brulikova L, Hlavac J (2011) Synthesis, reactivity and biological activity of 5-alkoxymethyluracil analogues. Beilstein J Org Chem 7:678\u2013698. https:\/\/doi.org\/10.3762\/bjoc.7.80","journal-title":"Beilstein J Org Chem"},{"key":"11641_CR24","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1135\/cccc19642576","volume":"29","author":"J Pliml","year":"1964","unstructured":"Pliml J, Sorm F (1964) Synthesis of 2\u2032-deoxy-D-ribofuranosyl-5-azacytosine. Collect Czech Chem Commun 29:2576\u20132577","journal-title":"Collect Czech Chem Commun"},{"key":"11641_CR25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/biom9110689","volume":"9","author":"D Janitschke","year":"2019","unstructured":"Janitschke D, Nelke C, Lauer AA et al (2019) Effect of caffeine and other methylxanthines on A\u03b2-homeostasis in SH-SY5Y cells. Biomolecules 9:689. https:\/\/doi.org\/10.3390\/biom9110689","journal-title":"Biomolecules"},{"key":"11641_CR26","doi-asserted-by":"publisher","first-page":"10852","DOI":"10.1039\/D4NJ01358A","volume":"48","author":"S Elmoussaoui","year":"2024","unstructured":"Elmoussaoui S, Lachhab S, El Mansouri AE et al (2024) A mild protocol for the development of an innovative green heterogeneous catalyst for the Hilbert-Johnson reaction. New J Chem 48:10852\u201310862. https:\/\/doi.org\/10.1039\/D4NJ01358A","journal-title":"New J Chem"},{"key":"11641_CR27","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/S0040-4039(01)83039-2","volume":"18","author":"ME Jung","year":"1977","unstructured":"Jung ME, Ornstein PL (1977) A new method for the efficient conversion of alcohols into iodides via treatment with trimethylsilyl iodide. Tetrahedron Lett 18:2659\u20132662","journal-title":"Tetrahedron Lett"},{"key":"11641_CR28","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1016\/S0040-4039(01)95258-X","volume":"46","author":"ME Jung","year":"1978","unstructured":"Jung ME, Hatfield GL (1978) Preparation of bromides from alcohols via treatment with trimethylsilyl bromide. Tetrahedron Lett 46:4483\u20134486","journal-title":"Tetrahedron Lett"},{"key":"11641_CR29","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1021\/jo00113a055","volume":"60","author":"DC Snyder","year":"1996","unstructured":"Snyder DC (1996) Conversion of alcohols to chlorides by TMSCl and DMSO. J Org Chem 60:2638\u20132639. https:\/\/doi.org\/10.1021\/jo00113a055","journal-title":"J Org Chem"},{"key":"11641_CR30","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.tet.2015.03.005","volume":"71","author":"XH Liu","year":"2015","unstructured":"Liu XH, Tan HB, He MT et al (2015) Isolation and synthesis of two hydroxychavicol heterodimers from Piper nudibaccatum. Tetrahedron 71:2369\u20132375. https:\/\/doi.org\/10.1016\/j.tet.2015.03.005","journal-title":"Tetrahedron"},{"key":"11641_CR31","doi-asserted-by":"publisher","first-page":"105412","DOI":"10.1039\/C6RA24254E","volume":"6","author":"E Valles","year":"2016","unstructured":"Valles E, Garc\u00eda PA, del Corral JMM et al (2016) Synthesis and cytotoxic evaluation of new terpenylpurines. RSC Adv 6:105412\u2013105420. https:\/\/doi.org\/10.1039\/C6RA24254E","journal-title":"RSC Adv"},{"key":"11641_CR32","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1038\/s41380-021-01138-6","volume":"26","author":"M Wainberg","year":"2021","unstructured":"Wainberg M, Luquez T, Koelle DM et al (2021) The viral hypothesis: how herpesviruses may contribute to Alzheimer\u2019s disease. Mol Psychiatry 26:5476\u20135480. https:\/\/doi.org\/10.1038\/s41380-021-01138-6","journal-title":"Mol Psychiatry"},{"key":"11641_CR33","doi-asserted-by":"publisher","first-page":"e032112","DOI":"10.1136\/bmjopen-2019-032112","volume":"10","author":"DP Devanand","year":"2020","unstructured":"Devanand DP, Andrews H, Kreisl WC et al (2020) Antiviral therapy: Valacyclovir treatment of Alzheimer\u2019s disease (VALAD) trial: protocol for a randomised, double-blind, placebo-controlled trial. BMJ Open 10:e032112. https:\/\/doi.org\/10.1136\/bmjopen-2019-032112","journal-title":"BMJ Open"},{"key":"11641_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-020-2837-5","volume":"20","author":"R Mogana","year":"2020","unstructured":"Mogana R, Adhikari A, Tzar MN et al (2020) Antibacterial activities of extracts from Canarium patentinervium Miq. BMC Complement Med Ther 20:1\u201311. https:\/\/doi.org\/10.1186\/s12906-020-2837-5","journal-title":"BMC Complement Med Ther"},{"key":"11641_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/157018012799129918","volume":"9","author":"S Prachayasittikul","year":"2012","unstructured":"Prachayasittikul S, Worachartcheewan A, Pingaew R et al (2012) Metal complexes of uracil derivatives with cytotoxicity and superoxide scavenging activity. Lett Drug Des Discov 9:282\u2013287. https:\/\/doi.org\/10.2174\/157018012799129918","journal-title":"Lett Drug Des Discov"},{"key":"11641_CR36","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.ica.2004.10.035","volume":"358","author":"W Lewandowski","year":"2005","unstructured":"Lewandowski W, Kalinowska M, Lewandowska H (2005) The influence of halogens on the electronic system of biologically important ligands. Inorg Chim Acta 358:2155\u20132166. https:\/\/doi.org\/10.1016\/j.ica.2004.10.035","journal-title":"Inorg Chim Acta"},{"key":"11641_CR37","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.3390\/molecules28227495","volume":"28","author":"EP Carreiro","year":"2023","unstructured":"Carreiro EP, Costa AR, Antunes CM et al (2023) Quercetin-1,2,3-triazole hybrids as multifunctional anti-Alzheimer\u2019s agents. Molecules 28:7495","journal-title":"Molecules"},{"key":"11641_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fgene.2018.00579","volume":"9","author":"L Xiaolei","year":"2018","unstructured":"Xiaolei L, Bin J, Lu S (2018) The epigenetics of Alzheimer\u2019s disease: factors and therapeutic implications. Front Genet 9:579. https:\/\/doi.org\/10.3389\/fgene.2018.00579","journal-title":"Front Genet"},{"key":"11641_CR39","doi-asserted-by":"publisher","first-page":"113623","DOI":"10.1016\/j.biopha.2022.113623","volume":"154","author":"C Zhehan","year":"2022","unstructured":"Zhehan C, Wenqiang X, Shuyuan J et al (2022) Effects of 5-Aza on neurogenesis contribute to learning and memory in the mouse hippocampus. Biomed Pharmacother 154:113623. https:\/\/doi.org\/10.1016\/j.biopha.2022.113623","journal-title":"Biomed Pharmacother"},{"key":"11641_CR40","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"11641_CR41","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"11641_CR42","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1:337\u2013341. https:\/\/doi.org\/10.1016\/j.ddtec.2004.11.007","journal-title":"Drug Discov Today Technol"},{"key":"11641_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55\u201368. https:\/\/doi.org\/10.1021\/cc9800071","journal-title":"J Comb Chem"},{"key":"11641_CR44","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y et al (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"key":"11641_CR45","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan WJ, Merz KM, Baldwin JJ (2000) Prediction of drug absorption using multivariate statistics. J Med Chem 43:3867\u20133877. https:\/\/doi.org\/10.1021\/jm000292e","journal-title":"J Med Chem"},{"key":"11641_CR46","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/jm015507e","volume":"44","author":"I Muegge","year":"2001","unstructured":"Muegge I, Heald SL, Brittelli D (2001) Simple selection criteria for drug-like chemical matter. J Med Chem 44:1841\u20131846. https:\/\/doi.org\/10.1021\/jm015507e","journal-title":"J Med Chem"},{"key":"11641_CR47","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s11095-010-0303-7","volume":"28","author":"X Liu","year":"2011","unstructured":"Liu X, Testa B, Fahr A (2011) Lipophilicity and its relationship with passive drug permeation. Pharm Res 28:962\u2013977. https:\/\/doi.org\/10.1007\/s11095-010-0303-7","journal-title":"Pharm Res"},{"key":"11641_CR48","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.4155\/fmc-2016-0165","volume":"8","author":"G Caron","year":"2016","unstructured":"Caron G, Ermondi G (2016) Molecular descriptors for polarity: the need for going beyond polar surface area. Future Med Chem 8:2013\u20132016. https:\/\/doi.org\/10.4155\/fmc-2016-0165","journal-title":"Future Med Chem"},{"key":"11641_CR49","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1021\/jm0492002","volume":"48","author":"YC Martin","year":"2005","unstructured":"Martin YC (2005) A bioavailability score. J Med Chem 48:3164\u20133170. https:\/\/doi.org\/10.1021\/jm0492002","journal-title":"J Med Chem"},{"key":"11641_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1602\/neurorx.2.1.15","volume":"2","author":"U Bickel","year":"2005","unstructured":"Bickel U (2005) How to measure drug transport across the blood-brain barrier. Neurotherapeutics 2:15\u201326. https:\/\/doi.org\/10.1602\/neurorx.2.1.15","journal-title":"Neurotherapeutics"},{"key":"11641_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1590\/S1984-82502012000300002","volume":"48","author":"KMR Srivalli","year":"2012","unstructured":"Srivalli KMR, Lakshmi PK (2012) Overview of P-glycoprotein inhibitors: a rational outlook. Braz J Pharm Sci 48:353\u2013367. https:\/\/doi.org\/10.1590\/S1984-82502012000300002","journal-title":"Braz J Pharm Sci"},{"key":"11641_CR52","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.3390\/app13106045","volume":"13","author":"D Iacopetta","year":"2023","unstructured":"Iacopetta D, Ceramella J, Catalano A et al (2023) Impact of cytochrome P450 enzymes on the Phase I metabolism of drugs. Appl Sci (Basel) 13:6045. https:\/\/doi.org\/10.3390\/app13106045","journal-title":"Appl Sci (Basel)"},{"key":"11641_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ddc4020024","volume":"4","author":"M Kond\u017ea","year":"2025","unstructured":"Kond\u017ea M, Buki\u0107 J, \u0106avar I, Tubi\u0107 B (2025) Targeted but troubling: CYP450 inhibition by kinase and PARP inhibitors and its clinical implications. DDC 4:24. https:\/\/doi.org\/10.3390\/ddc4020024","journal-title":"DDC"},{"key":"11641_CR54","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/genes11111295","volume":"11","author":"C Taylor","year":"2020","unstructured":"Taylor C, Crosby I, Yip V et al (2020) A review of the important role of CYP2D6 in pharmacogenomics. Genes (Basel) 11:1295. https:\/\/doi.org\/10.3390\/genes11111295","journal-title":"Genes (Basel)"},{"key":"11641_CR55","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1021\/ci300400a","volume":"52","author":"C Xu","year":"2012","unstructured":"Xu C, Cheng F, Chen L et al (2012) In silico prediction of chemical Ames mutagenicity. J Chem Inf Model 52:2840\u20132847. https:\/\/doi.org\/10.1021\/ci300400a","journal-title":"J Chem Inf Model"},{"key":"11641_CR56","doi-asserted-by":"publisher","first-page":"104615","DOI":"10.1016\/j.drudis.2026.104615","volume":"31","author":"CA Matos","year":"2026","unstructured":"Matos CA, Ali N, Augusto A et al (2026) Predictive value of the hERG assay for anticipating the arrhythmogenic potential of new drugs. Drug Discov Today 31:104615. https:\/\/doi.org\/10.1016\/j.drudis.2026.104615","journal-title":"Drug Discov Today"},{"key":"11641_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainres.2014.11.057","volume":"1597","author":"YJ Chae","year":"2015","unstructured":"Chae YJ, Lee HJ, Jeon JH et al (2015) Effects of donepezil on hERG potassium channels. Brain Res 1597:77\u201385. https:\/\/doi.org\/10.1016\/j.brainres.2014.11.057","journal-title":"Brain Res"},{"key":"11641_CR58","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s40001-024-01915-3","volume":"29","author":"I Iqbal","year":"2024","unstructured":"Iqbal I, Saqib F, Mubarak Z et al (2024) Alzheimer\u2019s disease and drug delivery across the blood\u2013brain barrier: approaches and challenges. Eur J Med Res 29:313. https:\/\/doi.org\/10.1186\/s40001-024-01915-3","journal-title":"Eur J Med Res"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11641-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11641-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:50:14Z","timestamp":1782863414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11641-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":58,"alternative-id":["11641"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11641-z","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}